Gene testing and digital twins for high cholesterol in Emiratis
Part of Genetic & congenital, Hormones & metabolism clinical trials.
This study uses whole genome sequencing and digital twin technology to better understand and manage very high cholesterol in Emirati adults. It aims to identify genetic causes and personalize treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an Emirati national between 18 and 55 years old.
- You have had at least two LDL (bad) cholesterol tests above 190 mg/dL (or 5.0 mmol/L) in the past year.
- You have not taken cholesterol-lowering medication in the last 3 months.
- You do not have a known diagnosis of familial hypercholesterolemia or other serious health conditions.
- You are not pregnant and have no untreated anxiety or depression.
- You can read and speak English or Arabic.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial focuses on people referred to a cholesterol (lipid) clinic to help identify inherited high cholesterol. It tests an “interpretive comment” approach to nudge detection—meaning it may help clinicians recognize who is most likely to have familial hypercholesterolemia.
This trial tests a one-time gene therapy (NGGT006) to treat a severe form of inherited high cholesterol that doesn't respond well to standard medications. It aims to lower cholesterol and reduce the risk of heart disease.
This trial focuses on people with familial hypercholesterolemia (FH), an inherited condition that causes very high cholesterol. It aims to better understand and manage severe cholesterol problems that raise heart risk, especially in families.
This trial tests a new injection called ART002g1 for people with a genetic condition that causes very high cholesterol. It aims to see if the drug is safe and can help lower cholesterol levels.
This trial tests an experimental medication called QLC7401 for people with a genetic condition that causes very high cholesterol. It aims to lower cholesterol levels safely and may be an option for those who need better control.
This trial aims to identify kids and teens who may have inherited high cholesterol (especially LDL) and may be at higher risk for early heart artery disease. It may help families learn about their risk and ensure the right follow-up and treatment plan.
Hear when a new Hypercholesterolemia, Autosomal Dominant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.